评估和管理无症状心房动
Jason G Andrade1,2,3, Marc W Deyell4,2, Richard Bennett4,2
1Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada jason.andrade@vch.ca.
Heart (British Cardiac Society)
|July 28, 2023
概括
心房动 (AF) 是一种常见的心律障碍,影响至少有3-4%的人口,尤其是在考虑无症状病例时. 本综述侧重于评估和管理无症状AF患者.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 公共卫生 公共卫生
背景情况:
- 心房动 (AF) 是最常见的持续心律失常.
- 虽然临床上明显的AF管理已经确立,但识别和治疗最小症状或无症状AF存在挑战.
- 在包括亚临床病例时,AF的患病率可能被低估,可能会影响3-4%的人口.
结论:
- 准确的评估和无症状AF的及时管理对于改善患者的治疗结果和减少心血管发病率至关重要.
- 需要进一步的研究来确定亚临床和设备检测AF的精确管理协议.
- 本综述为管理无症状心房的患者的临床医生提供了一个框架,强调了当前共识和未来研究方向的领域.
相关概念视频
Dysrhythmias V: Evaluating Dysrhythmias
42
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
42
Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Dysrhythmias VII: Nursing Management of Dysrhythmias
15
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
15


